Korean J Urol.  2008 Oct;49(10):912-916. 10.4111/kju.2008.49.10.912.

The Influences of Bladder Outlet Obstruction on Improvement of Storage Symptoms in Patients Who Underwent Transurethral Resection of Prostate

• Chung HY
• Han DS
• Jang YS
• Song KH

• KMID: 1204321
• DOI: http://doi.org/10.4111/kju.2008.49.10.912

Abstract

PURPOSE: To investigate the influences of preoperative bladder outlet obstruction(BOO) to be adjusted by age and prostate volume on improvement of storage symptoms in patients who underwent transurethral resection of prostate(TURP) in a long term follow up.
MATERIALS AND METHODS
We performed retrospective study of 75 patients with benign prostatic hyperplasia(BPH) who had undergone TURP and preoperative urodynamics from July 2004 to December 2006. 18 patients of them were lost follow up in this period, so we analyzed 57 patients in this study. The degrees of BOO were measured by the Abrams-Griffiths (AG) number calculated according to the preoperative urodynamic data. International Prostate Symptom Score(IPSS) questionnaire were used to evaluate improvement of symptoms. Especially IPSS questions number 2, 4 and 7 were used to evaluate storage symptoms. Partial correlation analysis was done between the AG numbers and the degree of storage symptoms improvement, adjusted by the age and the prostate volume.
RESULTS
There were significant decreases of the IPSS(p=0.029), storage symptom score(p=0.024) and frequency score(p=0.017) in BOO group compared to the non-BOO group. The changes of IPSS(gamma=-0.338, p=0.012), storage symptoms score(gamma=-0.292, p=0.031) and frequency symptom score (gamma=-0.305, p=0.023) were significantly correlated with AG number.
CONCLUSIONS
These results suggested that the preoperative AG number derived from urodynamics was an important factor in predicting the postoperative results. It would be expected that the patients with high AG numbers might be more improved storage symptom after TURP.

Keyword

Prostatic hyperplasia; Urodynamics; Urinary bladder neck obstruction; Transurethral resection of prostate

Figure

• 

  Fig. 1. Comparison of the changes of symptom scores before and after TURP between the patients with and without bladder outlet obstruction. The patients with bladder outlet obstruction showed significant decrease of IPSS, storge symptom score and frequency score after TURP comparing with the patients without bladder outlet obstruction (p＜0.05). Each bar is mean±SE. AG number: Abrams-Griffith number, TURP: transurethral resection of the prostate, BOO: bladder outlet obstruction.

Reference

References

1. Seki N, Takei M, Yamaguchi A, Naito S. Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement. Neurourol Urodyn. 2006; 25:428–32.

2. Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol. 2006; 49:651–8.

3. Cabelin MA, Te AE, Kaplan SA. Benign prostatic hyperplasia: challenges for the new millennium. Curr Opin Urol. 2000; 10:301–6.

4. Seki N, Yunoki T, Tomoda T, Takei M, Yamaguchi A, Naito S. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate. Neurourol Urodyn. 2008; 27:222–5.

5. Djavan B. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life. Urology. 2003; 62(3 Suppl 1):6–14.

6. Roehrborn CG. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol. 2008; 10:14–25.

7. Mirone V, Imbimbo C, Longo N, Fusco F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur Urol. 2007; 51:57–66.

8. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003; 170:530–47.

9. Tanaka Y, Masumori N, Itoh N, Furuya S, Ogura H, Tsukamoto T. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? Int J Urol. 2006; 13:1398–404.

10. Eckhardt MD, van Venrooij GE, Boon TA. Urethral resistance factor (URA) versus Schäfer's obstruction grade and Abrams-Griffiths (AG) number in the diagnosis of obstructive benign prostatic hyperplasia. Neurourol Urodyn. 2001; 20:175–85.

11. Hakenberg OW, Linne C, Manseck A, Wirth MP. Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement. Neurourol Urodyn. 2000; 19:585–93.

12. Oelke M, Hofner K, Jonas U, Ubbink D, de la Rosette J, Wijkstra H. Ultrasound measurement of detrusor wall thickness in healthy adults. Neurourol Urodyn. 2006; 25:308–17.

13. Kojima M, Inui E, Ochiai A, Nava Y, Ukimura O, Watanabe H. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol. 1997; 157:476–9.

14. Tubaro A, Carter S, Hind A, Vicentini C, Miano L. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol. 2001; 166:172–6.

15. Kojima M, Inui E, Ochiai A, Naya Y, Kamoi K, Ukimura O, et al. Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction. J Urol. 1997; 158:89–93.

16. Steers WD, Kolbeck S, Creedon D, Tuttle JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest. 1991; 88:1709–15.

17. Steers WD, Ciambotti J, Etzel B, Erdman S, de Groat WC. Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction. J Comp Neurol. 1991; 310:401–10.

18. Dinis P, Silva J, Ribeiro MJ, Avelino A, Reis M, Cruz F. Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: a pilot study. Eur Urol. 2004; 46:88–94.

19. Abrams P. Objective evaluation of bladder outlet obstruction. Br J Urol. 1995; 76(Suppl 1):11–5.

20. Andersson KE. LUTS treatment: future treatment options. Neurourol Urodyn. 2007; 26(6 Suppl):934–47.

21. Choi HJ, Lee KS. Detrusor overactivity in patients with benign prostatic obstruction: the clinical and urodynamic characteristic. Korean J Urol. 2005; 46:805–9.

22. Rosier PF, de la Rosette JJ. Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol. 1995; 13:9–13.

23. Lee KS, Hong SJ, Lee MS. The correlation between ultrasonic parameters of the prostate and the bladder outlet obstruction in BPH patients. Korean J Urol. 2000; 41:65–70.

24. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. The PLESS Study Group. Urology. 1999; 53:473–80.

25. Marberger MJ, Andersen JT, Nickel JC, Malice MP, Gabriel M, Pappas F, et al. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebocontrolled trials. Eur Urol. 2000; 38:563–8.

26. Laniado ME, Ockrim JL, Marronaro A, Tubaro A, Carter SS. Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int. 2004; 94:1283–6.

27. Jung YS, Hwang TK, Kim JC. The outcome and satisfaction of patients with lower urinary tract symptoms/benign prostatic hyperplasia following transurethral resection of the prostate according to urodynamic obstruction and the bladder function. Korean J Urol. 2007; 48:965–70.